Search / Trial NCT06230679

Effectiveness of NESA in the Treatment of Cancer Survivors

Launched by ANÍBAL BÁEZ SUÁREZ · Jan 19, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Cancer Physical Therapy Modality Electric Stimulation Therapy

Description

This study aims to evaluate NESA (or NESA non-invasive neuromodulation) to treat the most common long-term side effects in cancer survivors, due to the most used treatments. It will be compared between two groups of cancer survivors. The intervention group, with electrical stimulation, and the sham group, without electrical stimulation emission. The subjects will be assigned randomly. Neither the patient, the therapist, nor the analysts/researchers will know the assignment. Finally, this project aims to add a passive tool to the therapeutic arsenal of health professionals in the oncology ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Be a cancer survivor (5 years after discharge)
  • * Have 1 of the 3 symptoms of the most common cluster: sleep problems, chronic fatigue, chronic neuro-muscular pain.
  • Exclusion Criteria:
  • * Not have an active oncological process
  • * Present any of the contraindications of the NESA-XSignal device: pacemaker, internal bleeding, skin in poor condition (ulcerations or wounds), acute febrile processes, acute thrombophlebitis, pregnancy, phobia of electricity.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Santa Maria Del Camí, Balearic, Spain

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0